GNRH1 and neoplasm: Studies on the conjugates [DLys6]-LHRH-DOX and [DLys6]-LHRH-2-pyrrolino-DOX showed increased efficacy of doxorubicin, as the LHRH analog maintained its highly targeted binding affinity while the drug retained its cytotoxic effects on the tumor cells19, 20.